logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide CAS 137973-76-3

N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide CAS 137973-76-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 137973-76-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
CAS NO::
137973-76-3
Appearance::
Solid
Molecular Formula::
C26H23ClN2O3
Molecular Weight::
446.92500
EINECS NO::
NA
MDL NO::
MFCD19440797
CAS NO::
137973-76-3
Appearance::
Solid
Molecular Formula::
C26H23ClN2O3
Molecular Weight::
446.92500
EINECS NO::
NA
MDL NO::
MFCD19440797
N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide CAS 137973-76-3

Product Description:

Product Name:

N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide CAS NO: 137973-76-3


Synonyms:

7-chloro-1-[2-methyl-4-[(2-methylbenzoyl)amino]benzoyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine;

5-oxo-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetra-hydro-1H-benzoazepine;

7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)-benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-5-one;


Chemical & Physical Properties:

Appearance: Solid

Assay :≥99.00%

Density: 1.307

Boiling Point: 593.224℃ at 760 mmHg

Flash Point: 312.571℃

Vapor Pressure: 0.0±1.7 mmHg at 25℃

Index of Refraction: 1.655


Safety Information:

HS Code: 2933990090


5-Dehydro Tolvaptan is an impurity of Tolvaptan, a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.